Eton Pharmaceuticals (ETON) Raw Materials (2024 - 2026)

Eton Pharmaceuticals has disclosed Raw Materials across 3 years of filings, most recently posting $690000.0 for Q2 2026.

• In Q2 2026, Raw Materials changed N/A year-over-year to $690000.0; the TTM figure through Jun 2026 stood at $690000.0 (changed N/A YoY), while the FY2025 annual figure was $557000.0, down 89.6% from the prior year.
• Raw Materials came in at $690000.0 for Q2 2026 at Eton Pharmaceuticals, up from $557000.0 in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $5.4 million in Q4 2024 to a low of $557000.0 in Q4 2025.
• Average Raw Materials over 3 years is $2.2 million, with a median of $690000.0 recorded in 2026.
• The largest YoY upside for Raw Materials was 89.6% in 2025 against a maximum downside of 89.6% in 2025.
• Over 3 years, Raw Materials stood at $5.4 million in 2024, then plunged by 89.6% to $557000.0 in 2025, then climbed by 23.88% to $690000.0 in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $690000.0 in Q2 2026, $557000.0 in Q4 2025, and $5.4 million in Q4 2024.